Viewing Study NCT06320405


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2025-12-26 @ 1:58 AM
Study NCT ID: NCT06320405
Status: RECRUITING
Last Update Posted: 2025-06-22
First Post: 2024-03-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
Sponsor: OHSU Knight Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module